Wordt geladen...
CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials
Small molecule pharmacological inhibition of dominant human genetic disease is a feasible treatment that does not rely on the development of individual, patient-specific gene therapy vectors. However, the consequences of protein inhibition as a clinical therapeutic are not well-studied. In advance o...
Bewaard in:
| Gepubliceerd in: | Hum Mutat |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7493429/ https://ncbi.nlm.nih.gov/pubmed/31403230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/humu.23894 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|